Urethral Plate Flap vs. Tunica Vaginalis Flap for Residual Severe Ventral Curvature in Hypospadias

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age6-14
SponsorThe Children's Hospital of Zhejiang University School of Medicine

About this trial

The correction of ventral curvature in hypospadias follows a stepwise principle. Clinically, in some cases of hypospadias, residual severe ventral curvature (VC ≥ 30°) persists even after thorough skin degloving and transection of the urethral plate, due to the unbalanced development of the ventral and dorsal tunica albuginea of the corpus cavernosum. In such cases, ventral tunica albuginea incision and corporoplasty with a graft are mandatory.

Although the currently commonly used pedicled Tunica Vaginalis Flap (TVF) corporoplasty can effectively correct the curvature, it requires additional dissection of the scrotum and tunica vaginalis sac. This prolongs the operative time and poses risks of donor-site complications, such as testicular retraction and scrotal hematoma.

The novel Urethral Plate Flap (UPF) corporoplasty utilizes local pedicled urethral plate tissue for homologous repair. This study adopts a prospective, single-center, randomized, controlled, double-blind, non-inferiority trial design, enrolling 90 subjects. The aim is to verify that the therapeutic efficacy of the UPF technique in correcting such residual severe ventral curvature is non-inferior to that of TVF, while demonstrating significant advantages in surgical efficiency and donor-site safety.

This study aims, through a single-center, double-blind, RCT design, and under the strict indication of "residual severe ventral curvature after urethral plate transection," to verify efficacy via a "non-inferiority" hypothesis, and to verify safety and efficiency via a "superiority" hypothesis. The goal is to provide Level I evidence for the update of hypospadias guidelines, while simultaneously exploring the establishment of postoperative imaging evaluation standards.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: 6 months to 14 years.

Diagnosis: Primary hypospadias (no history of prior hypospadias repair).

Intraoperative Condition: Residual ventral curvature ≥ 30° confirmed by artificial erection test after transection of the urethral plate.

Consent: Signed informed consent provided by the participant's legal guardian.

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Urethral Plate Flap Corporoplasty

    Procedure/Surgery

    1.After degloving and transecting the urethral plate, mobilize the urethral plate. 2.Transect the tunica albuginea at the point of maximal curvature to fully correct the ventral curvature. 3.Mobilize and open the tunica vaginalis sac, and harvest a pedicled Tunica Vaginalis Flap (TVF). 4.Transfer the TVF to the ventral side to repair the tunica albuginea defect, and suture with 6-0 absorbable sutures. 5.Mobilize the space between the scrotal skin and dartos fascia. Place 2 interrupted sutures between the external spermatic fascia near the testis and the dartos fascia at the scrotal base to fix the testis within the sub-dartos space.

  • Tunica Vaginalis Flap Corporoplasty

    Procedure/Surgery

    1.After degloving and transecting the urethral plate, mobilize the urethral plate. 2.Transect the tunica albuginea at the point of maximal curvature to fully correct the ventral curvature. 3.Mobilize and open the tunica vaginalis sac, and harvest a pedicled Tunica Vaginalis Flap (TVF). 4.Transfer the TVF to the ventral side to repair the tunica albuginea defect, and suture with 6-0 absorbable sutures. 5.Mobilize the space between the scrotal skin and dartos fascia. Place 2 interrupted sutures between the external spermatic fascia near the testis and the dartos fascia at the scrotal base to fix the testis within the sub-dartos space.

Treatment groups

90 Participants
are divided into 2 treatment groups
Group A: Urethral Plate Flap CorporoplastyExperimental treatment 1 intervention
Group B: Tunica Vaginalis Flap CorporoplastyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Recurrence Rate of Ventral Curvature at 12 Months Postoperatively

Recurrence of ventral curvature is defined as residual ventral curvature ≥ 10° on lateral photographs during artificial erection.

Time frame
12 Months Postoperatively

Secondary outcomes

1

Operative Time for Curvature Correction

Recorded as the time from the "incision of the tunica albuginea" to the "completion of tunica albuginea repair and confirmation of a straight penis" (in minutes). This metric specifically excludes the time taken for urethroplasty and penile skin reconstruction to minimize confounding factors.

Time frame
Intraoperative
2

Incidence of Donor-Site Complications

Assessment of complications related to the graft harvest site, including: Testicular events: Postoperative testicular retraction/ascent (defined as the testis position being higher than the middle of the scrotum). Scrotal events: Scrotal hematoma, edema, and secondary infections caused by these conditions.

Time frame
From enrollment to the end of treatment at 12 months
3

Continuity of the tunica albuginea

Evaluation is performed by a sonographer blinded to group allocation using High-Frequency Penile Ultrasound Evaluation Evaluation Parameters: Continuity of the tunica albuginea (Categorized as: Continuous / Interrupted).

Time frame
12 months postoperatively
4

Echogenicity of the corpus cavernosum beneath the graft

Evaluation is performed by a sonographer blinded to group allocation using High-Frequency Penile Ultrasound Evaluation Evaluation Parameters: Echogenicity of the corpus cavernosum beneath the graft (Assessed for consistency with the host cavernous tissue)

Time frame
12 month postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: